Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +3.85% | +52.42% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 19-03-07 |
Munish Mehra
PRN | Corporate Officer/Principal | - | - |
George Samuel
SEC | Corporate Secretary | 43 | - |
Frank Lanza
AUD | Comptroller/Controller/Auditor | 62 | 15-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,658,684 | 54,849,986 ( 98.55 %) | 0 | 98.55 % |
Company contact information
Asterias Biotherapeutics, Inc.
2173 Salk Avenue Suite 200
92008, Carlsbad
+510 456 3800
http://asteriasbiotherapeutics.com/Sector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- AST Stock
- Company Asterias Biotherapeutics Inc